Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
The Oncologist|November 11, 2018
First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone DiseaseShawn Patrick Zinnen, Alexander Karpeisky, Daniel D Von Hoff, et al.
The American Journal of Emergency Medicine|December 18, 2007
Does intraosseous equal intravenous? A pharmacokinetic studyDaniel D Von Hoff, John G Kuhn, Howard A Burris, et al.
Oncotarget|November 2, 2017
CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin bindingNaoya Saito, Naoki Mine, Donald W Kufe, et al.
Cancer Discovery|November 5, 2011
Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second lookClifford J Whatcott, Haiyong Han, Richard G Posner, et al.
Rare Tumors|December 9, 2010
Molecular characterization of interdigitating dendritic cell sarcomaGlen J Weiss, Arlet Alarcon, Maqbool Halepota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cellsCaroline H Diep, Ruben M Munoz, Ashish Choudhary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
A phase I pharmacokinetic study of HMN-214, a novel oral stilbene derivative with polo-like kinase-1-interacting properties, in patients with advanced solid tumorsLinda L Garland, Charles Taylor, Deborah L Pilkington, et al.
Molecular Cancer Therapeutics|March 5, 2009
The small organic compound HMN-176 delays satisfaction of the spindle assembly checkpoint by inhibiting centrosome-dependent microtubule nucleationMichael A DiMaio, Alexei Mikhailov, Conly L Rieder, et al.
Drug Discovery Today|September 3, 2013
Targeting the nucleolus for cancer-specific activation of p53Denis Drygin, Sean E O'Brien, Ross D Hannan, et al.
Trends in Pharmacological Sciences|April 13, 2019
Triptolide and Its Derivatives as Cancer TherapiesPawan Noel, Daniel D Von Hoff, Ashok K Saluja, et al.
Pageof 22